Luye Pharma Group Ltd Financial Flexibility Index
Luye Pharma Group Ltd financial flexibility index. Luye Pharma Group Ltd (LUP) has a Financial Flexibility Index of 0.02x as of June 2023. Free cash flow of €344.86 Million (operating CF €344.86 Million minus capex €0.00) represents 0% of total liabilities (€14.11 Billion). See LUP cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Luye Pharma Group Ltd (2016–2025)
Financial flexibility index of Luye Pharma Group Ltd from 2016 to 2025. Historical Financial Flexibility Index trend for Luye Pharma Group Ltd across 10 annual periods. Check cash flow quality index of Luye Pharma Group Ltd to evaluate the quality of earnings relative to operating cash generation.
Luye Pharma Group Ltd Financial Flexibility Index by Year (2016–2025)
Luye Pharma Group Ltd financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Luye Pharma Group Ltd. For the full cash flow conversion analysis, see how efficiently does Luye Pharma Group Ltd generate cash.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | €2.79 Billion | €1.78 Billion | €14.47 Billion | ▲ +42.2% |
| 2024 | 0.14x | €1.88 Billion | €167.76 Million | €13.86 Billion | ▼ -41.3% |
| 2023 | 0.23x | €2.76 Billion | €1.60 Billion | €11.96 Billion | ▲ +8.2% |
| 2022 | 0.21x | €2.82 Billion | €1.65 Billion | €13.21 Billion | ▲ +289.0% |
| 2021 | 0.05x | €738.57 Million | €182.37 Million | €13.47 Billion | ▼ -60.2% |
| 2020 | 0.14x | €1.73 Billion | €1.03 Billion | €12.53 Billion | ▼ -43.5% |
| 2019 | 0.24x | €2.42 Billion | €1.42 Billion | €9.94 Billion | ▲ +31.9% |
| 2018 | 0.18x | €1.77 Billion | €1.05 Billion | €9.60 Billion | ▼ -51.5% |
| 2017 | 0.38x | €1.47 Billion | €964.10 Million | €3.86 Billion | ▲ +10.5% |
| 2016 | 0.34x | €911.17 Million | €592.03 Million | €2.64 Billion | — |